中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 5
May  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(5): 1229-1232

Advances in clinical research on liver disease during pregnancy

DOI: 10.3969/j.issn.1001-5256.2021.05.054

  • Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, China

  • Received Date: 2020-12-08
  • Accepted Date: 2021-01-20
  • Published Date: 2021-05-20
    Abstract
  • According to the association between liver injury and pregnancy, liver diseases during pregnancy can be classified as pregnancy-specific liver diseases and liver diseases with pregnancy. Pregnancy-specific liver diseases refer to the liver diseases that only occur during pregnancy, while liver diseases with pregnancy refer to pregnancy with previous liver diseases. Due to the particularity of maternal and fetal health during pregnancy, the diagnosis and treatment of liver diseases during pregnancy is challenging for both obstetricians and hepatologists. Rapid identification, diagnosis, and treatment of related diseases during pregnancy are very important for the prognosis of the mother and the fetus. This article summarizes and reviews the research advances in the epidemiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prognosis of liver diseases during pregnancy, in order to provide a reference for more clinicians.

     

    • FullText(HTML)
  • loading
    • References(26)
  • [1]
    MEHER S, DULEY L, HUNTER K, et al. Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: An individual participant data meta-analysis[J]. Am J Obstet Gynecol, 2017, 216(2): 121-128. e2. DOI: 10.1016/j.ajog.2016.10.016.
    [2]
    BRADY CW. Liver disease in pregnancy: What's new[J]. Hepatol Commun, 2020, 4(2): 145-156. DOI: 10.1002/hep4.1470.
    [3]
    ROBERGE S, NICOLAIDES K, DEMERS S, et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: Systematic review and meta-analysis[J]. Am J Obstet Gynecol, 2017, 216(2): 110-120. e6. DOI: 10.1016/j.ajog.2016.09.076.
    [4]
    American College of Obstetrician and Gynecologists. ACOG Practice Bulletin No. 202: Gestational hypertension and preeclampsia[J]. Obstet Gynecol, 2019, 133(1): 1-25. DOI: 10.1097/AOG.0000000000003018.
    [5]
    GAO Q, QU X, CHEN X, et al. Outcomes and risk factors of patients with acute fatty liver of pregnancy: A multicentre retrospective study[J]. Singapore Med J, 2018, 59(8): 425-430. DOI: 10.11622/smedj.2018001.
    [6]
    SHEKHAR S, DIDDI G. Liver disease in pregnancy[J]. Taiwan J Obstet Gynecol, 2015, 54(5): 475-482. DOI: 10.1016/j.tjog.2015.01.004.
    [7]
    WESTBROOK RH, DUSHEIKO G, WILLIAMSON C. Pregnancy and liver disease[J]. J Hepatol, 2016, 64(4): 933-945. DOI: 10.1016/j.jhep.2015.11.030.
    [8]
    Italian Association for the Study of the Liver (AISF), Italian Association for the Study of the Liver AISF. AISF position paper on liver disease and pregnancy[J]. Dig Liver Dis, 2016, 48(2): 120-137. DOI: 10.1016/j.dld.2015.11.004.
    [9]
    LIU J, GHAZIANI TT, WOLF JL. Acute fatty liver disease of pregnancy: Updates in pathogenesis, diagnosis, and management[J]. Am J Gastroenterol, 2017, 112(6): 838-846. DOI: 10.1038/ajg.2017.54.
    [10]
    CH'NG CL, MORGAN M, HAINSWORTH I, et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales[J]. Gut, 2002, 51(6): 876-880. DOI: 10.1136/gut.51.6.876.
    [11]
    SMITH DD, ROOD KM. Intrahepatic cholestasis of pregnancy[J]. Clin Obstet Gynecol, 2020, 63(1): 134-151. DOI: 10.1097/GRF.0000000000000495.
    [12]
    OZKAN S, CEYLAN Y, OZKAN OV, et al. Review of a challenging clinical issue: Intrahepatic cholestasis of pregnancy[J]. World J Gastroenterol, 2015, 21(23): 7134-7141. DOI: 10.3748/wjg.v21.i23.7134.
    [13]
    OVADIA C, SEED PT, SKLAVOUNOS A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: Results of aggregate and individual patient data meta-analyses[J]. Lancet, 2019, 393(10174): 899-909. DOI: 10.1016/S0140-6736(18)31877-4.
    [14]
    SMOLARCZYK R, GRYMOWICZ M, SIENKO J, et al. Successful perinatal outcome in an early onset intrahepatic cholestasis of pregnancy with extremely high serum hepatic function tests[J]. Gynecol Endocrinol, 2009, 25(7): 475-476. DOI: 10.1080/09513590902945147.
    [15]
    Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Guidelines for the management of intrahepatic cholestasis of pregnancy(2015)[J]. J Clin Hepatol, 2015, 31(10): 1575-1578. DOI: 10.3969/j.issn.1001-5256.2015.10.003.

    中华医学会妇产科学分会产科学组. 妊娠期肝内胆汁淤积症诊疗指南(2015)[J]. 临床肝胆病杂志, 2015, 31(10): 1575-1578. DOI: 10.3969/j.issn.1001-5256.2015.10.003.
    [16]
    CHAPPELL LC, BELL JL, SMITH A, et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): A randomised controlled trial[J]. Lancet, 2019, 394(10201): 849-860. DOI: 10.1016/S0140-6736(19)31270-X.
    [17]
    BINDER T, SALAJ P, ZIMA T, et al. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy[J]. J Perinat Med, 2006, 34(5): 383-391. DOI: 10.1515/JPM.2006.077.
    [18]
    TERRAULT NA, LOK A, MCMAHON BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance[J]. Hepatology, 2018, 67(4): 1560-1599. DOI: 10.1002/hep.29800.
    [19]
    Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association; Chinese Society of Perinatal Medicine, Chinese Medical Association. 2020 clinical guidelines on prevention of mother-to-child transmission of hepatitis B virus[J]. J Clin Hepatol, 2020, 36(7): 1474-1481. DOI: 10.3760/cma.j.cn112141-20200213-00101.

    中华医学会妇产科学分会产科学组, 中华医学会围产医学分会. 乙型肝炎病毒母婴传播预防临床指南(2020)[J]. 临床肝胆病杂志, 2020, 36(7): 1474-1481. DOI: 10.3760/cma.j.cn112141-20200213-00101.
    [20]
    CONNELL LE, SALIHU HM, SALEMI JL, et al. Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes[J]. Liver Int, 2011, 31(8): 1163-1170. DOI: 10.1111/j.1478-3231.2011.02556.x.
    [21]
    PERGAM SA, WANG CC, GARDELLA CM, et al. Pregnancy complications associated with hepatitis C: Data from a 2003-2005 Washington state birth cohort[J]. Am J Obstet Gynecol, 2008, 199(1): 38. e1-9. DOI: 10.1016/j.ajog.2008.03.052.
    [22]
    MAST EE, HWANG LY, SETO DS, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy[J]. J Infect Dis, 2005, 192(11): 1880-1889. DOI: 10.1086/497701.
    [23]
    CHAPPELL CA, SCARSI KK, KIRBY BJ, et al. Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: A phase 1 pharmacokinetic study[J]. Lancet Microbe, 2020, 1(5): e200-e208. DOI: 10.1016/S2666-5247(20)30062-8.
    [24]
    GARCIA-TSAO G, ABRALDES JG, BERZIGOTTI A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology, 2017, 65(1): 310-335. DOI: 10.1002/hep.28906.
    [25]
    JUNG YM, LEE SM, HONG S, et al. The risk of pregnancy-associated hypertension in women with nonalcoholic fatty liver disease[J]. Liver Int, 2020, 40(10): 2417-2426. DOI: 10.1111/liv.14563.
    [26]
    LEE SM, KWAK SH, KOO JN, et al. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus[J]. Diabetologia, 2019, 62(2): 238-248. DOI: 10.1007/s00125-018-4779-8.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (544) PDF downloads(125) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return